Back to UBS Group AG UBS Group AG

ZYZYBT
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in ZHENGYE BIOTECHNOLOGY HLDG L

UBS Group AG holds 7,992 shares of ZYBT (ZHENGYE BIOTECHNOLOGY HLDG L), worth $5,410 as of 2026-Q2. The position was decreased (-0.6% shares).

Current Value

$5,410

Current Shares

7,992

Total Value Change

-$1,525

Total Shares Change

+6,703

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
7,992
-0.6%
$5,4100.0%$0.68
0
2026-Q1
Decreased
8,036
-11.8%
$7,5140.0%$0.77
0
2025-Q4
Increased
9,115
+110.6%
$10,4830.0%$1.13
19
2025-Q3
Decreased
4,329
-97.2%
$11,3420.0%$2.19
0
2025-Q2
Increased
154,512
+119x
$922,4370.0%$6.61
40
2025-Q1
New
1,289
-
$6,9350.0%$5.11
25

Other major holders of ZYBT: JANE STREET GROUP, LLC, Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used